{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:58:23Z","timestamp":1792425503725,"version":"4.5.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81902633"],"award-info":[{"award-number":["81902633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LY20H160028"],"award-info":[{"award-number":["LY20H160028"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02544-w","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T15:59:28Z","timestamp":1731599968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinicopathologic feature and treatment progress of high-grade ovarian neuroendocrine tumors"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2566-8482","authenticated-orcid":false,"given":"Qionghua","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"issue":"1","key":"2544_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","volume":"122","author":"GJ Gardner","year":"2011","unstructured":"Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: a society of gynecologic oncology (SGO) clinical document. Gynecol Oncol. 2011;122(1):190\u20138.","journal-title":"Gynecol Oncol"},{"issue":"23","key":"2544_CR2","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1002\/cam4.4368","volume":"10","author":"L Pang","year":"2021","unstructured":"Pang L, Guo Z. Primary neuroendocrine tumors of the ovary: management and outcomes. Cancer Med. 2021;10(23):8558\u201369.","journal-title":"Cancer Med"},{"issue":"6","key":"2544_CR3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11912-022-01217-z","volume":"24","author":"EN Rizen","year":"2022","unstructured":"Rizen EN, Phan AT. Neuroendocrine tumors: a relevant clinical update. Curr Oncol Rep. 2022;24(6):703\u201314.","journal-title":"Curr Oncol Rep"},{"key":"2544_CR4","doi-asserted-by":"crossref","first-page":"103344","DOI":"10.1016\/j.critrevonc.2021.103344","volume":"162","author":"G Caruso","year":"2021","unstructured":"Caruso G, Sassu CM, Tomao F, et al. The puzzle of gynecologic neuroendocrine carcinomas: state of the art and future directions. Crit Rev Oncol Hematol. 2021;162:103344.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2544_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071835","author":"M Virarkar","year":"2022","unstructured":"Virarkar M, Vulasala SS, Morani AC, et al. Neuroendocrine neoplasms of the gynecologic tract. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14071835.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"2544_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ygyno.2021.04.039","volume":"162","author":"I Winer","year":"2021","unstructured":"Winer I, Kim C, Gehrig P. Neuroendocrine tumors of the gynecologic tract update. Gynecol Oncol. 2021;162(1):210\u20139.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2544_CR7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ygyno.2014.05.017","volume":"134","author":"M Atienza-Amores","year":"2014","unstructured":"Atienza-Amores M, Guerini-Rocco E, Soslow RA, Park KJ, Weigelt B. Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions. Gynecol Oncol. 2014;134(2):410\u20138.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"2544_CR8","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.3390\/curroncol29100617","volume":"29","author":"J Wang","year":"2022","unstructured":"Wang J, Ning Y, Du Y, Kang Y. Lymphadenectomy benefits small cell carcinoma of ovary: a population-based analysis. Curr Oncol. 2022;29(10):7802\u201315.","journal-title":"Curr Oncol"},{"issue":"1","key":"2544_CR9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12020-022-03067-y","volume":"77","author":"W Huang","year":"2022","unstructured":"Huang W, Bao Y, Luo X, Yao L, Yuan L. Neuroendocrine neoplasms of the ovary: an analysis of clinicopathological characteristics and prognosis with a focus on histological grading. Endocrine. 2022;77(1):188\u201398.","journal-title":"Endocrine"},{"issue":"2","key":"2544_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/ijgc-2019-000746","volume":"30","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Meng F, Fang H, Zhang Z, Wang L, Zheng W. Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary. Int J Gynecol Cancer. 2020;30(2):207\u201312.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"2544_CR11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1159\/000507978","volume":"13","author":"E Oneda","year":"2020","unstructured":"Oneda E, Zorzi F, Gorio A, et al. Differential diagnosis of small cell carcinoma of the ovary or ovarian metastases of small cell carcinoma of the lung: a case report and review of the literature. Case Rep Oncol. 2020;13(2):822\u20138.","journal-title":"Case Rep Oncol"},{"issue":"9 Suppl 3","key":"2544_CR12","first-page":"S30","volume":"24","author":"NS Reed","year":"2014","unstructured":"Reed NS, Pautier P, \u00c5vall-Lundqvist E, et al. Gynecologic cancer intergroup (GCIG) consensus review for ovarian small cell cancers. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S30-34.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"2544_CR13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/1066896920947788","volume":"29","author":"P Gupta","year":"2021","unstructured":"Gupta P, Kapatia G, Gupta N, et al. Small cell carcinoma of the ovary: clinicopathologic and immunohistochemical analysis of 7 new cases of a rare malignancy. Int J Surg Pathol. 2021;29(3):236\u201345.","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"2544_CR14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","volume":"46","author":"P Jelinic","year":"2014","unstructured":"Jelinic P, Mueller JJ, Olvera N, et al. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat Genet. 2014;46(5):424\u20136.","journal-title":"Nat Genet"},{"issue":"9","key":"2544_CR15","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/PAS.0000000000000475","volume":"39","author":"M Karanian-Philippe","year":"2015","unstructured":"Karanian-Philippe M, Velasco V, Longy M, et al. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas. Am J Surg Pathol. 2015;39(9):1197\u2013205.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2544_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","volume":"46","author":"L Witkowski","year":"2014","unstructured":"Witkowski L, Carrot-Zhang J, Albrecht S, et al. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet. 2014;46(5):438\u201343.","journal-title":"Nat Genet"},{"issue":"23","key":"2544_CR17","doi-asserted-by":"crossref","first-page":"e10900","DOI":"10.1097\/MD.0000000000010900","volume":"97","author":"L Yin","year":"2018","unstructured":"Yin L, Li J, Wei Y, Ma D, Sun Y, Sun Y. Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: a case report and literature review. Medicine (Baltimore). 2018;97(23):e10900.","journal-title":"Medicine (Baltimore)"},{"key":"2544_CR18","doi-asserted-by":"publisher","DOI":"10.24920\/004183","author":"X Chen","year":"2023","unstructured":"Chen X, Liu HL, Wang JS, Zhao FH. Primary ovarian small cell carcinoma of pulmonary type: analysis of 6 cases and review of 31 cases in the literatures. Chin Med Sci J. 2023. https:\/\/doi.org\/10.24920\/004183.","journal-title":"Chin Med Sci J"},{"issue":"2","key":"2544_CR19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2018.02.004","volume":"149","author":"JR Patibandla","year":"2018","unstructured":"Patibandla JR, Fehniger JE, Levine DA, Jelinic P. Small cell cancers of the female genital tract: molecular and clinical aspects. Gynecol Oncol. 2018;149(2):420\u20137.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"2544_CR20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00000478-199210000-00002","volume":"16","author":"JH Eichhorn","year":"1992","unstructured":"Eichhorn JH, Young RH, Scully RE. Primary ovarian small cell carcinoma of pulmonary type. A clinicopathologic, immunohistologic, and flow cytometric analysis of 11 cases. Am J Surg Pathol. 1992;16(10):926\u201338.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2544_CR21","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1055\/s-0032-1328658","volume":"73","author":"K M\u00fcnstedt","year":"2013","unstructured":"M\u00fcnstedt K, Estel R, Dreyer T, Kurata A, Benz A. Small cell ovarian carcinomas\u2014characterisation of two rare tumor entities. Geburtshilfe Frauenheilkd. 2013;73(7):698\u2013704.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"1","key":"2544_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.30699\/ijp.13.1.99","volume":"13","author":"S Agarwal","year":"2018","unstructured":"Agarwal S, Pandey P, Ralli M, Singh S. Ovarian small cell carcinoma: a rare case report and review of literature. Iran J Pathol. 2018;13(1):99\u2013102.","journal-title":"Iran J Pathol"},{"issue":"5","key":"2544_CR23","first-page":"467","volume":"51","author":"H Jin","year":"2022","unstructured":"Jin H, An R, Liu ZH, Liu AJ. Endometrioid carcinoma of uterus and small-cell neuroendocrine carcinoma of both ovary: report of a case. Zhonghua Bing Li Xue Za Zhi. 2022;51(5):467\u20139.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"2544_CR24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.gore.2018.02.003","volume":"24","author":"E Kalampokas","year":"2018","unstructured":"Kalampokas E, Sharma V, Gagliardi T, Payne F, Gurumurthy M. Primary small cell ovarian cancer of pulmonary type: a case report. Gynecol Oncol Rep. 2018;24:10\u20133.","journal-title":"Gynecol Oncol Rep"},{"issue":"5","key":"2544_CR25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1066896915586254","volume":"23","author":"A Rubio","year":"2015","unstructured":"Rubio A, Schuldt M, Chamorro C, Crespo-Lora V, Nogales FF. Ovarian small cell carcinoma of pulmonary type arising in mature cystic teratomas with metastases to the contralateral ovary. Int J Surg Pathol. 2015;23(5):388\u201392.","journal-title":"Int J Surg Pathol"},{"key":"2544_CR26","first-page":"4383216","volume":"2018","author":"S Terada","year":"2018","unstructured":"Terada S, Suzuki T, Hasegawa A, Nakayama S, Adachi H. The cytoreductive effect of radiotherapy for small cell ovarian carcinoma of the pulmonary type: a case report and review of the literature. Case Rep Obstet Gynecol. 2018;2018:4383216.","journal-title":"Case Rep Obstet Gynecol"},{"issue":"4","key":"2544_CR27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1440-1827.2012.02804.x","volume":"62","author":"H Ikota","year":"2012","unstructured":"Ikota H, Kaneko K, Takahashi S, et al. Malignant transformation of ovarian mature cystic teratoma with a predominant pulmonary type small cell carcinoma component. Pathol Int. 2012;62(4):276\u201380.","journal-title":"Pathol Int"},{"key":"2544_CR28","doi-asserted-by":"crossref","first-page":"954289","DOI":"10.3389\/fonc.2022.954289","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Wu Y, Zhang Y, Li X. Case report: Strategies for improving outcomes in patients with primary ovarian small-cell neuroendocrine carcinoma. Front Oncol. 2022;12:954289.","journal-title":"Front Oncol"},{"issue":"5","key":"2544_CR29","first-page":"380","volume":"47","author":"LM Qu","year":"2018","unstructured":"Qu LM, Zhong YP, Guo L, Ni JS. Mucinous cystadenocarcinoma of ovary associated with neuroendocrine carcinoma (primary ovarian pulmonary-type small cell carcinoma): report of a case. Zhonghua Bing Li Xue Za Zhi. 2018;47(5):380\u20132.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"5","key":"2544_CR30","first-page":"297","volume":"31","author":"T Ozpacaci","year":"2012","unstructured":"Ozpacaci T, Tamam MO, Mulazimoglu M, Kamali G, Ozcan D. Isolated adrenal metastasis of small cell neuroendocrine carcinoma of the ovary detected with FDG-PET\/CT. Rev Esp Med Nucl Imagen Mol. 2012;31(5):297\u20138.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"7","key":"2544_CR31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/dc.24160","volume":"47","author":"P Gupta","year":"2019","unstructured":"Gupta P, Jogunoori S, Rajwanshi A, et al. Cytologic diagnosis of small cell carcinoma of the ovary: a case report with review of the literature. Diagn Cytopathol. 2019;47(7):701\u20135.","journal-title":"Diagn Cytopathol"},{"key":"2544_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57121338","author":"TA Georgescu","year":"2021","unstructured":"Georgescu TA, Bohiltea RE, Munteanu O, et al. Emerging therapeutic concepts and latest diagnostic advancements regarding neuroendocrine tumors of the gynecologic tract. Medicina (Kaunas). 2021. https:\/\/doi.org\/10.3390\/medicina57121338.","journal-title":"Medicina (Kaunas)"},{"key":"2544_CR33","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.2147\/CMAR.S314686","volume":"13","author":"L Pang","year":"2021","unstructured":"Pang L, Yang H, Ning Y, Zheng C. Retrospective analysis of clinicopathological features and prognosis of gynecological small-cell carcinoma. Cancer Manag Res. 2021;13:4529\u201340.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"2544_CR34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminoncol.2006.10.028","volume":"34","author":"S Crowder","year":"2007","unstructured":"Crowder S, Tuller E. Small cell carcinoma of the female genital tract. Semin Oncol. 2007;34(1):57\u201363.","journal-title":"Semin Oncol"},{"issue":"2","key":"2544_CR35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.24920\/004183","volume":"38","author":"X Chen","year":"2023","unstructured":"Chen X, Liu HL, Wang JS, Zhao FH. Primary ovarian small cell carcinoma of pulmonary type: analysis of 6 cases and review of 31 cases in the literatures. Chin Med Sci J. 2023;38(2):130\u20137.","journal-title":"Chin Med Sci J"},{"issue":"1","key":"2544_CR36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12905-023-02722-4","volume":"23","author":"BJ Feng","year":"2023","unstructured":"Feng BJ, Li TH, Li YH, et al. Case series of ovarian neuroendocrine carcinoma: overview of clinicopathological features. BMC Womens Health. 2023;23(1):595.","journal-title":"BMC Womens Health"},{"key":"2544_CR37","doi-asserted-by":"crossref","first-page":"100925","DOI":"10.1016\/j.gore.2022.100925","volume":"39","author":"AS Asom","year":"2022","unstructured":"Asom AS, Lastra RR, Hasan Y, Weinberg L, Fleming GF, Kurnit KC. Small cell carcinoma of the ovary, pulmonary type: a role for adjuvant radiotherapy after carboplatin and etoposide? Gynecol Oncol Rep. 2022;39:100925.","journal-title":"Gynecol Oncol Rep"},{"issue":"8","key":"2544_CR38","first-page":"e9879","volume":"12","author":"EM Sieloff","year":"2020","unstructured":"Sieloff EM, Baumgartner M, Schauer M, Shattuck B. A case of lethal abdominal compartment syndrome due to rapidly expanding ovarian small cell carcinoma pulmonary type. Cureus. 2020;12(8):e9879.","journal-title":"Cureus"},{"issue":"1","key":"2544_CR39","first-page":"65","volume":"49","author":"F Guan","year":"2020","unstructured":"Guan F, Yan HL, Chen FF, He HH. Clinicopathological analysis of ovarian composite neuroendocrine carcinoma. Zhonghua Bing Li Xue Za Zhi. 2020;49(1):65\u20137.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"2","key":"2544_CR40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cyt.12918","volume":"32","author":"A Ishikawa","year":"2021","unstructured":"Ishikawa A, Fujisawa H, Yasumura N, et al. Ovarian pulmonary-type small cell carcinoma diagnosed by means of ascitic fluid cytology: a case report with immunocytochemical analysis. Cytopathology. 2021;32(2):250\u20132.","journal-title":"Cytopathology"},{"issue":"11","key":"2544_CR41","doi-asserted-by":"crossref","first-page":"152619","DOI":"10.1016\/j.prp.2019.152619","volume":"215","author":"J Wei","year":"2019","unstructured":"Wei J, Wang Y, Li P, Fan L, Li M, Wang Z. Small-cell carcinoma-associated ovarian mucinous carcinoma: a case report and literature review. Pathol Res Pract. 2019;215(11):152619.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"2544_CR42","first-page":"710","volume":"37","author":"R Kumasaka","year":"2016","unstructured":"Kumasaka R, Yokoyama Y, Fuchinoue K, et al. A case of ovarian small cell carcinoma of the pulmonary type that was observed as it developed. Eur J Gynaecol Oncol. 2016;37(5):710\u20133.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"5","key":"2544_CR43","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PGP.0b013e31826d7ea8","volume":"32","author":"A Kurasaki","year":"2013","unstructured":"Kurasaki A, Sakurai N, Yamamoto Y, Taoka H, Takahashi K, Kubushiro K. Ovarian pulmonary-type small cell carcinoma: case report and review of the literature. Int J Gynecol Pathol. 2013;32(5):464\u201370.","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"2544_CR44","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.4081\/rt.2012.e26","volume":"4","author":"N Kira","year":"2012","unstructured":"Kira N, Takai N, Ishii T, et al. Ovarian small cell carcinoma complicated by carcinomatous meningitis. Rare Tumors. 2012;4(2):e26.","journal-title":"Rare Tumors"},{"issue":"3","key":"2544_CR45","first-page":"312","volume":"33","author":"D Tsolakidis","year":"2012","unstructured":"Tsolakidis D, Papanikolaou A, Ktenidis K, Pervana S. Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature. Eur J Gynaecol Oncol. 2012;33(3):312\u20135.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"2544_CR46","first-page":"43","volume":"23","author":"M Reckova","year":"2010","unstructured":"Reckova M, Mego M, Rejlekova K, Sycova-Mila Z, Obertova Z, Mardiak J. Small-cell carcinoma of the ovary with breast metastases: a case report. Klin Onkol. 2010;23(1):43\u20135.","journal-title":"Klin Onkol"},{"issue":"31","key":"2544_CR47","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1200\/JCO.2008.16.4640","volume":"26","author":"Z Cheng","year":"2008","unstructured":"Cheng Z, Yin H, Du J, Yue X, Qian X, Liu B. Bilateral breast metastasis from small-cell carcinoma of the ovary. J Clin Oncol. 2008;26(31):5129\u201330.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2544_CR48","first-page":"777","volume":"51","author":"L Sang-wook","year":"2008","unstructured":"Sang-wook L, Woo-seok S, Han-moe P, Sang-so L, Ji-cheol Ji, Dae-woon E, Gil-hyun K. 1 case of pulmonary small cell carcinoma of the ovary with large mucinous adenocarcinoma. Obstet Gynecol Sci. 2008;51(7):777\u201383.","journal-title":"Obstet Gynecol Sci"},{"key":"2544_CR49","first-page":"563","volume":"72","author":"J Kim","year":"2007","unstructured":"Kim J, Kim Y, Seong H, et al. Primary small cell carcinoma of the ovary and the long-term survival after systemic chemotherapy. Korean J Med. 2007;72:563\u20137.","journal-title":"Korean J Med"},{"issue":"4","key":"2544_CR50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/pgp.0b013e318039373a","volume":"26","author":"M Grandjean","year":"2007","unstructured":"Grandjean M, Legrand L, Waterkeyn M, et al. Small cell carcinoma of pulmonary type inside a microinvasive mucinous cystadenocarcinoma of the ovary: a case report. Int J Gynecol Pathol. 2007;26(4):426\u201331.","journal-title":"Int J Gynecol Pathol"},{"issue":"4c","key":"2544_CR51","first-page":"2685","volume":"27","author":"M Saitoh-Sekiguchi","year":"2007","unstructured":"Saitoh-Sekiguchi M, Nakahara K, Kojimahara T, et al. Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report. Anticancer Res. 2007;27(4c):2685\u20137.","journal-title":"Anticancer Res"},{"issue":"2","key":"2544_CR52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1447-0756.2007.00494.x","volume":"33","author":"N Suzuki","year":"2007","unstructured":"Suzuki N, Kameyama K, Hirao T, Susumu N, Mukai M, Aoki D. A case of pulmonary type of ovarian small cell carcinoma. J Obstet Gynaecol Res. 2007;33(2):203\u20136.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"2544_CR53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ygyno.2006.01.001","volume":"102","author":"K Hirabayashi","year":"2006","unstructured":"Hirabayashi K, Yasuda M, Osamura RY, Hirasawa T, Murakami M. Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis. Gynecol oncol. 2006;102(1):111\u20137.","journal-title":"Gynecol oncol"},{"issue":"2","key":"2544_CR54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.pai.0000155796.49278.62","volume":"14","author":"CR Rund","year":"2006","unstructured":"Rund CR, Fischer EG. Perinuclear dot-like cytokeratin 20 staining in small cell neuroendocrine carcinoma of the ovary (pulmonary-type). Appl Immunohistochem Mol Morphol. 2006;14(2):244\u20138.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"2544_CR55","first-page":"239","volume":"25","author":"J Mebis","year":"2004","unstructured":"Mebis J, De Raeve H, Baekelandt M, Tjalma WA, Vermorken JB. Primary ovarian small cell carcinoma of the pulmonary type: a case report and review of the literature. Eur J Gynaecol Oncol. 2004;25(2):239\u201341.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"2544_CR56","first-page":"373","volume":"65","author":"S Sundersingh","year":"2003","unstructured":"Sundersingh S, Rajasundaram S, Majhi U. Bilataeral adrenal metastases from bilateral small cell neuroendocrine carcinoma of the ovary. Indian J Surg. 2003;65(4):373\u20134.","journal-title":"Indian J Surg"},{"issue":"3","key":"2544_CR57","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/PL00012039","volume":"5","author":"F Kawasaki","year":"2000","unstructured":"Kawasaki F, Takai N, Narahara H, Yokoyama S, Miyakawa I. A rare case of bilateral small cell carcinoma of the ovary diagnosed during pregnancy. Int J Clin Oncol. 2000;5(3):200\u20133.","journal-title":"Int J Clin Oncol"},{"issue":"10","key":"2544_CR58","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1440-1827.1998.tb03846.x","volume":"48","author":"SC Lim","year":"1998","unstructured":"Lim SC, Choi SJ, Suh CH. A case of small cell carcinoma arising in a mature cystic teratoma of the ovary. Pathol Int. 1998;48(10):834\u20139.","journal-title":"Pathol Int"},{"issue":"3","key":"2544_CR59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1097-0339(199809)19:3<177::AID-DC4>3.0.CO;2-A","volume":"19","author":"HJ Shin","year":"1998","unstructured":"Shin HJ, Caraway NP. Fine-needle aspiration biopsy of metastatic small cell carcinoma from extrapulmonary sites. Diagn Cytopathol. 1998;19(3):177\u201381.","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"2544_CR60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01092759","volume":"430","author":"M Fukunaga","year":"1997","unstructured":"Fukunaga M, Endo Y, Miyazawa Y, Ushigome S. Small cell neuroendocrine carcinoma of the ovary. Virchows Arch. 1997;430(4):343\u20138.","journal-title":"Virchows Arch"},{"issue":"2","key":"2544_CR61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00004347-199604000-00012","volume":"15","author":"K Jones","year":"1996","unstructured":"Jones K, Diaz JA, Donner LR. Neuroendocrine carcinoma arising in an ovarian mucinous cystadenoma. Int J Gynecol Pathol. 1996;15(2):167\u201370.","journal-title":"Int J Gynecol Pathol"},{"issue":"10","key":"2544_CR62","first-page":"1032","volume":"118","author":"KK Khurana","year":"1994","unstructured":"Khurana KK, Tornos C, Silva EG. Ovarian neuroendocrine carcinoma-associated with a mucinous neoplasm. Arch Pathol Lab Med. 1994;118(10):1032\u20134.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2544_CR63","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0090-8258(92)90265-K","volume":"46","author":"DH Chang","year":"1992","unstructured":"Chang DH, Hsueh S, Soong YK. Small cell carcinoma with neurosecretory granules arising in an ovarian dermoid cyst. Gynecol Oncol. 1992;46(2):246\u201350.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2544_CR64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02390091","volume":"248","author":"RJ Collins","year":"1991","unstructured":"Collins RJ, Cheung A, Ngan HY, Wong LC, Chan SY, Ma HK. Primary mixed neuroendocrine and mucinous carcinoma of the ovary. Arch Gynecol Obstet. 1991;248(3):139\u201343.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"2544_CR65","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.semdp.2013.06.007","volume":"30","author":"M Rouzbahman","year":"2013","unstructured":"Rouzbahman M, Clarke B. Neuroendocrine tumors of the gynecologic tract: select topics. Semin Diagn Pathol. 2013;30(3):224\u201333.","journal-title":"Semin Diagn Pathol"},{"key":"2544_CR66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.critrevonc.2017.10.007","volume":"120","author":"S Boussios","year":"2017","unstructured":"Boussios S, Moschetta M, Zarkavelis G, Papadaki A, Kefas A, Tatsi K. Ovarian sex-cord stromal tumours and small cell tumours: pathological, genetic and management aspects. Crit Rev Oncol Hematol. 2017;120:43\u201351.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"2544_CR67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11912-017-0617-2","volume":"19","author":"BE Howitt","year":"2017","unstructured":"Howitt BE, Kelly P, McCluggage WG. Pathology of neuroendocrine tumours of the female genital tract. Curr Oncol Rep. 2017;19(9):59.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"2544_CR68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/IGC.0000000000000888","volume":"27","author":"HC B\u00f6sm\u00fcller","year":"2017","unstructured":"B\u00f6sm\u00fcller HC, Wagner P, Pham DL, et al. CD56 (neural cell adhesion molecule) expression in ovarian carcinomas: association with high-grade and advanced stage but not with neuroendocrine differentiation. Int J Gynecol Cancer. 2017;27(2):239\u201345.","journal-title":"Int J Gynecol Cancer"},{"issue":"15","key":"2544_CR69","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","volume":"26","author":"M Tischkowitz","year":"2020","unstructured":"Tischkowitz M, Huang S, Banerjee S, et al. Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and current management guidelines. Clin Cancer Res. 2020;26(15):3908\u201317.","journal-title":"Clin Cancer Res"},{"key":"2544_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217282","author":"NR Field","year":"2024","unstructured":"Field NR, Dickson KA, Nassif NT, Marsh DJ. SMARCA4 and SMARCA2 co-deficiency: an uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling. Cancer Lett. 2024. https:\/\/doi.org\/10.1016\/j.canlet.2024.217282.","journal-title":"Cancer Lett"},{"issue":"1","key":"2544_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.5705","volume":"255","author":"M Andrianteranagna","year":"2021","unstructured":"Andrianteranagna M, Cyrta J, Masliah-Planchon J, et al. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type. J Pathol. 2021;255(1):1\u201315.","journal-title":"J Pathol"},{"issue":"4","key":"2544_CR72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5114\/pjp.2013.39331","volume":"64","author":"J Kupryja\u0144czyk","year":"2013","unstructured":"Kupryja\u0144czyk J, Dansonka-Mieszkowska A, Moes-Sosnowska J, et al. Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. A pilot study. Pol J Pathol. 2013;64(4):238\u201346.","journal-title":"Pol J Pathol"},{"issue":"1","key":"2544_CR73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/jca.26978","volume":"10","author":"B Lu","year":"2019","unstructured":"Lu B, Shi H. An in-depth look at small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): clinical implications from recent molecular findings. J Cancer. 2019;10(1):223\u201337.","journal-title":"J Cancer"},{"issue":"6","key":"2544_CR74","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.pap.0000138146.357376.1e","volume":"11","author":"WG McCluggage","year":"2004","unstructured":"McCluggage WG. Ovarian neoplasms composed of small round cells\u2014a review. Adv Anat Pathol. 2004;11(6):288\u201396.","journal-title":"Adv Anat Pathol"},{"issue":"11","key":"2544_CR75","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","volume":"18","author":"RH Young","year":"1994","unstructured":"Young RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol. 1994;18(11):1102\u201316.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2544_CR76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13691-019-00365-7","volume":"8","author":"J Kitazawa","year":"2019","unstructured":"Kitazawa J, Takahashi A, Uemura M, Hayashi Y. Small-cell lung carcinoma with ovarian metastasis 4 years after the first-line treatment. Int Cancer Conf J. 2019;8(3):109\u201313.","journal-title":"Int Cancer Conf J"},{"issue":"1","key":"2544_CR77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):3.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2544_CR78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/gmit.gmit_105_21","volume":"11","author":"R Yadav","year":"2022","unstructured":"Yadav R, Chopra K, Jaiswal N, Aggarwal S. Primary pure large-cell neuroendocrine carcinoma of the ovary: a rare case report. Gynecol Minim Invasive Ther. 2022;11(3):176\u20138.","journal-title":"Gynecol Minim Invasive Ther"},{"issue":"1","key":"2544_CR79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13048-019-0543-z","volume":"12","author":"X Yang","year":"2019","unstructured":"Yang X, Chen J, Dong R. Pathological features, clinical presentations and prognostic factors of ovarian large cell neuroendocrine carcinoma: a case report and review of published literature. J Ovarian Res. 2019;12(1):69.","journal-title":"J Ovarian Res"},{"issue":"2","key":"2544_CR80","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5306\/wjco.v5.i2.36","volume":"5","author":"IA Voutsadakis","year":"2014","unstructured":"Voutsadakis IA. Large cell neuroendocrine carcinoma of the ovary: a pathologic entity in search of clinical identity. World J Clin Oncol. 2014;5(2):36\u20138.","journal-title":"World J Clin Oncol"},{"key":"2544_CR81","doi-asserted-by":"crossref","first-page":"891699","DOI":"10.3389\/fonc.2022.891699","volume":"12","author":"L Pang","year":"2022","unstructured":"Pang L, Guo Z. Differences in characteristics and outcomes between large-cell neuroendocrine carcinoma of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study. Front Oncol. 2022;12:891699.","journal-title":"Front Oncol"},{"issue":"1","key":"2544_CR82","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13048-018-0474-0","volume":"11","author":"Y Inada","year":"2018","unstructured":"Inada Y, Nakai G, Yamamoto K, et al. Rapidly growing juvenile granulosa cell tumor of the ovary arising in adult: a case report and review of the literature. J Ovarian Res. 2018;11(1):100.","journal-title":"J Ovarian Res"},{"issue":"1","key":"2544_CR83","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10147-008-0805-z","volume":"14","author":"H Kaur","year":"2009","unstructured":"Kaur H, Bagga R, Saha SC, et al. Juvenile granulosa cell tumor of the ovary presenting with pleural effusion and ascites. Int J Clin Oncol. 2009;14(1):78\u201381.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"2544_CR84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cncy.22502","volume":"130","author":"LN Edmund","year":"2022","unstructured":"Edmund LN, Salama AM, Murali R. Cytologic features of sex cord-stromal tumors in women. Cancer Cytopathol. 2022;130(1):55\u201371.","journal-title":"Cancer Cytopathol"},{"issue":"11","key":"2544_CR85","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/ijgc-2022-003978","volume":"32","author":"A Mohamed","year":"2022","unstructured":"Mohamed A, Ali A, Younis FM. Ovarian dysgerminoma. Int J Gynecol Cancer. 2022;32(11):1490\u20131.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2544_CR86","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.semdp.2022.07.004","volume":"40","author":"P Ramalingam","year":"2023","unstructured":"Ramalingam P. Germ cell tumors of the ovary: a review. Semin Diagn Pathol. 2023;40(1):22\u201336.","journal-title":"Semin Diagn Pathol"},{"key":"2544_CR87","doi-asserted-by":"crossref","first-page":"151966","DOI":"10.1016\/j.anndiagpath.2022.151966","volume":"59","author":"PQ Deb","year":"2022","unstructured":"Deb PQ, Heller DS. Extrauterine endometrial stromal sarcoma: a systematic review and outcome analysis. Ann Diagn Pathol. 2022;59:151966.","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"2544_CR88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.semdp.2022.01.004","volume":"39","author":"S Niu","year":"2022","unstructured":"Niu S, Zheng W. Endometrial stromal tumors: diagnostic updates and challenges. Semin Diagn Pathol. 2022;39(3):201\u201312.","journal-title":"Semin Diagn Pathol"},{"issue":"5","key":"2544_CR89","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/j.sempedsurg.2016.09.005","volume":"25","author":"A Hayes-Jordan","year":"2016","unstructured":"Hayes-Jordan A, LaQuaglia MP, Modak S. Management of desmoplastic small round cell tumor. Semin Pediatr Surg. 2016;25(5):299\u2013304.","journal-title":"Semin Pediatr Surg"},{"key":"2544_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18157819","author":"M Koz\u0142owski","year":"2021","unstructured":"Koz\u0142owski M, Nowak K, Kordek A, Cymbaluk-P\u0142oska A. Therapeutic management of rare primary ovarian neoplasms: carcinosarcoma, leiomyosarcoma, melanoma and carcinoid. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18157819.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2544_CR91","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4103\/IJPM.IJPM_548_16","volume":"61","author":"I Vanidassane","year":"2018","unstructured":"Vanidassane I, Kumar S, Gunasekar S, Mathur SR, Phulware R, Rastogi S. Primary rhabdomyosarcoma in ovary\u2014pathologist clinches it all. Indian J Pathol Microbiol. 2018;61(1):134\u20136.","journal-title":"Indian J Pathol Microbiol"},{"issue":"5","key":"2544_CR92","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/CCO.0000000000000321","volume":"28","author":"NS Reed","year":"2016","unstructured":"Reed NS. Neuroendocrine tumours of the gynecological tract. Curr Opin Oncol. 2016;28(5):412\u20138.","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"2544_CR93","first-page":"3091","volume":"35","author":"O Jamy","year":"2015","unstructured":"Jamy O, Yaghmour G, Hare F, Martin MG. Population-based analysis of the clinical features of primary small cell carcinoma of the ovary. Anticancer Res. 2015;35(5):3091\u20135.","journal-title":"Anticancer Res"},{"issue":"5","key":"2544_CR94","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/IGC.0000000000001243","volume":"28","author":"D Nasioudis","year":"2018","unstructured":"Nasioudis D, Chapman-Davis E, Frey MK, Caputo TA, Witkin SS, Holcomb K. Small cell carcinoma of the ovary: a rare tumor with a poor prognosis. Int J Gynecol Cancer. 2018;28(5):932\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"5 Pt 2","key":"2544_CR95","first-page":"846","volume":"91","author":"JL Powell","year":"1998","unstructured":"Powell JL, McAfee RD, McCoy RC, Shiro BS. Uterine and ovarian conservation in advanced small cell carcinoma of the ovary. Obstet Gynecol. 1998;91(5 Pt 2):846\u20138.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2544_CR96","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13048-016-0259-2","volume":"9","author":"G Yaghmour","year":"2016","unstructured":"Yaghmour G, Prouet P, Wiedower E, et al. Genomic alterations in neuroendocrine cancers of the ovary. J Ovarian Res. 2016;9(1):52.","journal-title":"J Ovarian Res"},{"key":"2544_CR97","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcancer.2019.05.012","volume":"59","author":"MK Ediriweera","year":"2019","unstructured":"Ediriweera MK, Tennekoon KH, Samarakoon SR. Role of the PI3K\/AKT\/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol. 2019;59:147\u201360.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"2544_CR98","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/1568009623666230209121732","volume":"23","author":"F Aliyuda","year":"2023","unstructured":"Aliyuda F, Moschetta M, Ghose A, et al. Advances in ovarian cancer treatment beyond PARP inhibitors. Curr Cancer Drug Targets. 2023;23(6):433\u201346.","journal-title":"Curr Cancer Drug Targets"},{"key":"2544_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna8050064","author":"S Miglietta","year":"2022","unstructured":"Miglietta S, Girolimetti G, Marchio L, et al. MicroRNA and metabolic profiling of a primary ovarian neuroendocrine carcinoma pulmonary-type reveals a high degree of similarity with small cell lung cancer. Noncoding RNA. 2022. https:\/\/doi.org\/10.3390\/ncrna8050064.","journal-title":"Noncoding RNA"},{"issue":"6","key":"2544_CR100","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.12998\/wjcc.v12.i6.1111","volume":"12","author":"XY Xing","year":"2024","unstructured":"Xing XY, Zhang W, Liu LY, Han LP. Clinical analysis of 12 cases of ovarian neuroendocrine carcinoma. World J Clin Cases. 2024;12(6):1111\u20139.","journal-title":"World J Clin Cases"},{"key":"2544_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/bios12080617","author":"V Singh","year":"2022","unstructured":"Singh V, Sheikh A, Abourehab MAS, Kesharwani P. Dostarlimab as a miracle drug: rising hope against cancer treatment. Biosensors (Basel). 2022. https:\/\/doi.org\/10.3390\/bios12080617.","journal-title":"Biosensors (Basel)"},{"issue":"3","key":"2544_CR102","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaoncol.2022.5631","volume":"9","author":"WJ Petty","year":"2023","unstructured":"Petty WJ, Paz-Ares L. Emerging strategies for the treatment of small cell lung cancer: a review. JAMA Oncol. 2023;9(3):419\u201329.","journal-title":"JAMA Oncol"},{"issue":"5","key":"2544_CR103","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000488996","volume":"41","author":"MM Weber","year":"2018","unstructured":"Weber MM, Fottner C. Immune checkpoint inhibitors in the treatment of patients with neuroendocrine neoplasia. Oncol Res Treat. 2018;41(5):306\u201312.","journal-title":"Oncol Res Treat"},{"issue":"11","key":"2544_CR104","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oncolo\/oyac161","volume":"27","author":"J Yao","year":"2022","unstructured":"Yao J, Bergsland E, Aggarwal R, et al. DLL3 as an emerging target for the treatment of neuroendocrine neoplasms. Oncologist. 2022;27(11):940\u201351.","journal-title":"Oncologist"},{"key":"2544_CR105","unstructured":"Niraparib and dostarlimab for the treatment of small cell lung cancer and other high-grade neuroendocrine carcinomas. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04701307. Accessed 5 Jan 2024."},{"key":"2544_CR106","unstructured":"Secured access to pembrolizumab for patients with selected rare cancer types (AcS\u00e9).https:\/\/clinicaltrials.gov\/study\/NCT03012620. Accessed 5 Jan 2024."},{"key":"2544_CR107","unstructured":"Phase-II study of Lu177DOTATOC in adults with STTR (+) pulmonary, pheochromocytoma, paraganglioma, unknown primary, thymus NETs (PUTNET), or any other non-.GEP-NET. (PUTNET). https:\/\/clinicaltrials.gov\/study\/NCT04276597. Accessed 5 Jan 2024."},{"key":"2544_CR108","unstructured":"RRx-001 in lung cancer, ovarian cancer and neuroendocrine tumors prior to re-administration of platinum based doublet regimens (QUADRUPLE THREAT) (n.d.). https:\/\/clinicaltrials.gov\/study\/NCT02489903. Accessed 5 Jan 2024."},{"key":"2544_CR109","unstructured":"Trial of topotecan with VX-970 (M6620), an ATR kinase inhibitor, in small cell cancers and extrapulmonary small cell cancers\u2014full text view\u2014clinicaltrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/study\/NCT02487095. Accessed 5 Jan 2024."},{"key":"2544_CR110","doi-asserted-by":"crossref","first-page":"836910","DOI":"10.3389\/fmed.2022.836910","volume":"9","author":"L Pang","year":"2022","unstructured":"Pang L, Wang S. Prevalence, associated factors, and survival outcomes of small-cell neuroendocrine carcinoma of the gynecologic tract: a large population-based analysis. Front Med (Lausanne). 2022;9:836910.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2544_CR111","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/PGP.0b013e31817fb419","volume":"28","author":"H Yasuoka","year":"2009","unstructured":"Yasuoka H, Tsujimoto M, Fujita S, et al. Monoclonality of composite large cell neuroendocrine carcinoma and mucinous epithelial tumor of the ovary: a case study. Int J Gynecol Pathol. 2009;28(1):55\u20138.","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"2544_CR112","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.prp.2009.01.013","volume":"205","author":"J Ch\u00eanevert","year":"2009","unstructured":"Ch\u00eanevert J, Bessette P, Plante M, T\u00eatu B, Dub\u00e9 V. Mixed ovarian large cell neuroendocrine carcinoma, mucinous adenocarcinoma, and teratoma: a report of two cases and review of the literature. Pathol Res Pract. 2009;205(9):657\u201361.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"2544_CR113","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12022-021-09689-8","volume":"33","author":"R Maragliano","year":"2022","unstructured":"Maragliano R, Libera L, Carnevali I, et al. Mixed neuroendocrine\/non-neuroendocrine neoplasm (MiNEN) of the ovary arising from endometriosis: molecular pathology analysis in support of a pathogenetic paradigm. Endocr Pathol. 2022;33(3):400\u201310.","journal-title":"Endocr Pathol"},{"key":"2544_CR114","doi-asserted-by":"crossref","first-page":"203636132096840","DOI":"10.1177\/2036361320968401","volume":"12","author":"G Burkeen","year":"2020","unstructured":"Burkeen G, Chauhan A, Agrawal R, et al. Gynecologic large cell neuroendocrine carcinoma: a review. Rare Tumors. 2020;12:2036361320968401.","journal-title":"Rare Tumors"},{"issue":"11","key":"2544_CR115","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1200\/OP.20.00189","volume":"16","author":"CH Lee","year":"2020","unstructured":"Lee CH, Jeon SY, Kim HS, et al. Cushing syndrome as a result of an adrenocorticotropin-producing large-cell neuroendocrine carcinoma of the ovary. JCO Oncol Pract. 2020;16(11):760\u20133.","journal-title":"JCO Oncol Pract"},{"key":"2544_CR116","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2147\/CMAR.S366771","volume":"14","author":"J Qiu","year":"2022","unstructured":"Qiu J, Xu J, Yao G, Zhu F, Wang Y, Fu Y. An ovarian large-cell neuroendocrine carcinoma accompanied by clear cell carcinoma with specific high level of AFP: case report and review of the literature. Cancer Manag Res. 2022;14:2235\u201341.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"2544_CR117","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.pgp.0000139655.18062.12","volume":"23","author":"S Ohira","year":"2004","unstructured":"Ohira S, Itoh K, Shiozawa T, et al. Ovarian non-small cell neuroendocrine carcinoma with paraneoplastic parathyroid hormone-related hypercalcemia. Int J Gynecol Pathol. 2004;23(4):393\u20137.","journal-title":"Int J Gynecol Pathol"},{"key":"2544_CR118","doi-asserted-by":"crossref","first-page":"970985","DOI":"10.3389\/fonc.2022.970985","volume":"12","author":"L Pang","year":"2022","unstructured":"Pang L, Chen J, Chang X. Large-cell neuroendocrine carcinoma of the gynecologic tract: prevalence, survival outcomes, and associated factors. Front Oncol. 2022;12:970985.","journal-title":"Front Oncol"},{"issue":"6","key":"2544_CR119","first-page":"667","volume":"63","author":"S Cokmert","year":"2014","unstructured":"Cokmert S, Demir L, Doganay L, et al. Large cell neuroendocrine carcinoma of the ovary and its skin metastases: a case report and review of the literature. West Indian Med J. 2014;63(6):667\u201372.","journal-title":"West Indian Med J"},{"issue":"6","key":"2544_CR120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3892\/etm.2011.325","volume":"2","author":"T Oshita","year":"2011","unstructured":"Oshita T, Yamazaki T, Akimoto Y, et al. Clinical features of ovarian large-cell neuroendocrine carcinoma: four case reports and review of the literature. Exp Ther Med. 2011;2(6):1083\u201390.","journal-title":"Exp Ther Med"},{"issue":"2","key":"2544_CR121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0463.2007.apm_570.x","volume":"115","author":"CF Lindboe","year":"2007","unstructured":"Lindboe CF. Large cell neuroendocrine carcinoma of the ovary. APMIS. 2007;115(2):169\u201376.","journal-title":"APMIS"},{"issue":"4","key":"2544_CR122","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004347-199610000-00002","volume":"15","author":"JH Eichhorn","year":"1996","unstructured":"Eichhorn JH, Lawrence WD, Young RH, Scully RE. Ovarian neuroendocrine carcinomas of non-small-cell type associated with surface epithelial adenocarcinomas. A study of five cases and review of the literature. Int J Gynecol Pathol. 1996;15(4):303\u201314.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"2544_CR123","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/PGP.0b013e31816bcda4","volume":"27","author":"P Mhawech-Fauceglia","year":"2008","unstructured":"Mhawech-Fauceglia P, Odunsi K, Dim D, et al. Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: mystery resolved? Int J Gynecol Pathol. 2008;27(4):539\u201346.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"2544_CR124","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2463\/mrms.ci.2016-0150","volume":"16","author":"M Takeuchi","year":"2017","unstructured":"Takeuchi M, Matsuzaki K, Tsuneyama K, Nishimura M, Takiguchi E, Harada M. Ovarian large cell neuroendocrine carcinoma associated with serous carcinoma: correlation of pathology with MR imaging. Magn Reson Med Sci. 2017;16(4):273\u20134.","journal-title":"Magn Reson Med Sci"},{"issue":"6","key":"2544_CR125","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000477487","volume":"61","author":"HJ Trichia","year":"2017","unstructured":"Trichia HJ, Tziakou P, Papatheodorou DC, Lekka J. Cytological features of the large cell variant of small cell ovarian carcinoma in young patients with hypercalcemia: histological findings and review of the literature. Acta Cytol. 2017;61(6):462\u20138.","journal-title":"Acta Cytol"},{"issue":"4 Pt 2","key":"2544_CR126","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1447-0756.2008.00916.x","volume":"34","author":"T Tsuji","year":"2008","unstructured":"Tsuji T, Togami S, Shintomo N, Fukamachi N, Douchi T, Taguchi S. Ovarian large cell neuroendocrine carcinoma. J Obstet Gynaecol Res. 2008;34(4 Pt 2):726\u201330.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"2544_CR127","first-page":"4093","volume":"15","author":"N Herold","year":"2018","unstructured":"Herold N, Wappenschmidt B, Markiefka B, et al. Non-small cell neuroendocrine carcinoma of the ovary in a BRCA2-germline mutation carrier: a case report and brief review of the literature. Oncol Lett. 2018;15(4):4093\u20136.","journal-title":"Oncol Lett"},{"key":"2544_CR128","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X241266415","author":"M Wang","year":"2024","unstructured":"Wang M, Gao F, Wang X, Guo Y, Zhang H. Pure large-cell neuroendocrine carcinoma of the ovary with a somatic BRCA1 mutation: the first reported case and the review of the literature. SAGE Open Med Case Rep. 2024. https:\/\/doi.org\/10.1177\/2050313X241266415.","journal-title":"SAGE Open Med Case Rep"},{"key":"2544_CR129","doi-asserted-by":"crossref","first-page":"1339806","DOI":"10.3389\/fonc.2024.1339806","volume":"14","author":"Y Xing","year":"2024","unstructured":"Xing Y, Cao Y, Wu X, Chen Y, Wang Y. Trastuzumab deruxtecan effectively controlled recurrent ovarian large-cell neuroendocrine carcinoma with low-level HER-2 expression: a case report. Front Oncol. 2024;14:1339806.","journal-title":"Front Oncol"},{"issue":"4","key":"2544_CR130","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.4081\/rt.2011.e41","volume":"3","author":"S Shahabi","year":"2011","unstructured":"Shahabi S, Pellicciotta I, Hou J, et al. Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus. Rare Tumors. 2011;3(4):e41.","journal-title":"Rare Tumors"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02544-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:19:54Z","timestamp":1737530394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02544-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["2544"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02544-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"2"}}